Wang Y - Search Results

1

Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.

Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Yang T, et al. Among authors: wang j, wang y. Nanomedicine. 2012 Jan;8(1):81-92. doi: 10.1016/j.nano.2011.05.003. Epub 2011 May 20. Nanomedicine. 2012. PMID: 21664295

2

NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.

Wang X, Wang Y, Chen X, Wang J, Zhang X, Zhang Q. Wang X, et al. Among authors: wang j, wang y. J Control Release. 2009 Oct 1;139(1):56-62. doi: 10.1016/j.jconrel.2009.05.030. Epub 2009 May 24. J Control Release. 2009. PMID: 19470394

3

RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.

Wang Y, Wang X, Zhang Y, Yang S, Wang J, Zhang X, Zhang Q. Wang Y, et al. Among authors: wang x, wang j. J Drug Target. 2009 Jul;17(6):459-67. doi: 10.1080/10611860902974085. J Drug Target. 2009. PMID: 19527117

4

Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro.

Wang Y, Yang T, Wang X, Wang J, Zhang X, Zhang Q. Wang Y, et al. Among authors: wang x, wang j. Pharm Res. 2010 Sep;27(9):1861-8. doi: 10.1007/s11095-010-0184-9. Epub 2010 Jun 18. Pharm Res. 2010. PMID: 20559700

5

Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.

Wang Y, Yang T, Wang X, Dai W, Wang J, Zhang X, Li Z, Zhang Q. Wang Y, et al. Among authors: wang x, wang j. J Control Release. 2011 Feb 10;149(3):299-306. doi: 10.1016/j.jconrel.2010.10.027. Epub 2010 Oct 31. J Control Release. 2011. PMID: 21044651

6

Linkage with cathepsin B-sensitive dipeptide promotes the in vitro and in vivo anticancer activity of PEGylated tumor necrosis factor-alpha (TNF-α) against murine fibrosarcoma.

Dai C, Fu Y, Li B, Wang Y, Zhang X, Wang J, Zhang Q. Dai C, et al. Among authors: wang j, wang y. Sci China Life Sci. 2011 Feb;54(2):128-38. doi: 10.1007/s11427-010-4124-z. Epub 2011 Feb 14. Sci China Life Sci. 2011. PMID: 21318482 Free article.

7

Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma.

Dai W, Yang T, Wang Y, Wang X, Wang J, Zhang X, Zhang Q. Dai W, et al. Among authors: wang x, wang j, wang y. Nanomedicine. 2012 Oct;8(7):1152-61. doi: 10.1016/j.nano.2012.01.003. Epub 2012 Jan 31. Nanomedicine. 2012. PMID: 22306158

8

Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.

Wang Y, Wei X, Zhang C, Zhang F, Liang W. Wang Y, et al. Ther Deliv. 2010 Aug;1(2):273-87. doi: 10.4155/tde.10.24. Ther Deliv. 2010. PMID: 22816133 Review.

9

Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.

Chen B, Dai W, He B, Zhang H, Wang X, Wang Y, Zhang Q. Chen B, et al. Among authors: wang x, wang y. Theranostics. 2017 Jan 7;7(3):538-558. doi: 10.7150/thno.16684. eCollection 2017. Theranostics. 2017. PMID: 28255348 Free PMC article. Review.

10

A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.

Liang Y, Li S, Wang X, He B, He B, Dai W, Zhang H, Wang X, Wang Y, Zhou D, Zhang Q. Liang Y, et al. Among authors: wang x, wang y. Theranostics. 2017 Jul 23;7(13):3306-3318. doi: 10.7150/thno.20242. eCollection 2017. Theranostics. 2017. PMID: 28900511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293,149 results

Search Page

Filters